Replies to post #4314 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s fully-diluted share count @3/31/25=28.02M—an increase of 0.07M shares since 12/31/24.

The 28.02M figure consists of: 21.38M basic shares on the 3/31/25 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001177648/000095017025071340/enta-20250331.htm#consolidated_balance_sheets ); and 6.64M options and unvested restricted-stock shares and equivalents (whether or not exercisable) (ibid, p.9).

NOTE: My method of counting fully-diluted shares is intentionally a maximum-case scenario—i.e. intentionally conservative for calculating enterprise value. My count includes all options, regardless of how far out of the money they may be.